Kadlubowski M, Irvine W J, Rowland A C
Endocrine Unit, Royal Infirmary, Edinburgh.
J Clin Lab Immunol. 1987 Nov;24(3):105-11.
The nature of the humoral immune response in patients with Graves' ophthalmopathy has been investigated using a solid phase 125I Protein A binding assay. Retro-orbital muscle (R.O.M.), skeletal muscle (Sk.M.), R.O.M.-membranes, thyroid, kidney, liver, harderian gland, acetylcholine receptors (AchR), actin and myosin were used as target antigens. No significant difference in antibody binding profile to R.O.M. and Sk.M. was found indicating that the ophthalmic immunoglobulins (OIgs) were not recognising a R.O.M. specific antigen(s). Comparison between R.O.M. and R.O.M.-membranes, however, revealed that these antigens were detecting very different antibody populations. Using the former, it appeared that the predominant antibody population being measured was anti-myosin whereas the latter appeared to be detecting primarily anti-AchR antibodies. Anti-actin antibodies were also present in some of the sera. Thus a spectrum of anti-R.O.M. antibodies appears to be present in Graves' ophthalmopathy but the cross-reactivity of these with non-R.O.M. skeletal muscle and their similarity to those found in myasthenia gravis prevent them as yet being used to explain the specific immunopathology observed in this disease.
采用固相¹²⁵I蛋白A结合试验,对格雷夫斯眼病患者体液免疫反应的性质进行了研究。以眶后肌(R.O.M.)、骨骼肌(Sk.M.)、R.O.M.膜、甲状腺、肾脏、肝脏、哈德氏腺、乙酰胆碱受体(AchR)、肌动蛋白和肌球蛋白作为靶抗原。未发现针对R.O.M.和Sk.M.的抗体结合谱有显著差异,这表明眼部免疫球蛋白(OIgs)未识别出R.O.M.特异性抗原。然而,R.O.M.与R.O.M.膜之间的比较显示,这些抗原检测到的抗体群体非常不同。使用前者时,所检测到的主要抗体群体似乎是抗肌球蛋白,而使用后者时,似乎主要检测到抗AchR抗体。部分血清中也存在抗肌动蛋白抗体。因此,格雷夫斯眼病患者似乎存在一系列抗R.O.M.抗体,但这些抗体与非R.O.M.骨骼肌的交叉反应性以及它们与重症肌无力中发现的抗体的相似性,使得它们目前尚无法用于解释该疾病中观察到的特定免疫病理学现象